Company Filing History:
Years Active: 2014-2024
Title: The Innovative Contributions of Carlos N Sanrame
Introduction
Carlos N Sanrame is a prominent inventor based in Lexington, MA, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable strides in developing innovative treatments for various diseases.
Latest Patents
Among his latest patents is the invention titled "Prodrugs of fumarates and their use in treating various diseases." This invention provides compounds of formula (I) and pharmaceutical compositions that are crucial in treating neurological diseases, such as multiple sclerosis. The advancements in this area highlight his commitment to improving patient outcomes through innovative drug development.
Career Highlights
Carlos currently works at Alkermes Pharma Ireland Limited, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients suffering from debilitating conditions.
Collaborations
Throughout his career, Carlos has collaborated with notable colleagues, including Tarek A Zeidan and Scott M Duncan. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Carlos N Sanrame's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in advancing medical science. His innovative work continues to inspire future generations of researchers and inventors.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.